Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Curis (CRIS) Research & Development (2016 - 2025)

Curis' Research & Development history spans 16 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Research & Development fell 35.05% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $28.3 million, down 26.73%, while the annual FY2025 figure was $28.3 million, 26.73% down from the prior year.
  • Research & Development reached $5.8 million in Q4 2025 per CRIS's latest filing, down from $6.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $12.3 million in Q2 2022 to a low of $5.8 million in Q4 2025.
  • Average Research & Development over 5 years is $9.2 million, with a median of $9.4 million recorded in 2023.
  • Peak YoY movement for Research & Development: soared 92.05% in 2021, then crashed 35.05% in 2025.
  • A 5-year view of Research & Development shows it stood at $10.8 million in 2021, then dropped by 19.18% to $8.7 million in 2022, then increased by 14.45% to $10.0 million in 2023, then decreased by 10.0% to $9.0 million in 2024, then plummeted by 35.05% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRIS's Research & Development are $5.8 million (Q4 2025), $6.4 million (Q3 2025), and $7.5 million (Q2 2025).